Status:
COMPLETED
Study of Metabolites Markers in Adjuvant Breast Cancer
Lead Sponsor:
Centre Antoine Lacassagne
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
10+ years
Brief Summary
The breast cancer is composed of multiple biological entities. Recent progress in molecular biology, DNA or RNA chip, permitted the global tumour genome or transcriptome study. Those technics, leads t...
Eligibility Criteria
Inclusion
- Patient with breast cancer who undergoes a initial surgery with frozen preservation of the surgical specimen in the Centre Antoine Lacassagne tumor bank
- Patient who sign the Biological research center consent allowing the the preservation of tumor and blood sample in biobank and use of the sample for research purpose
Exclusion
- other treatment the initial surgery (neodjuvant chemotherapy...)
- Absence of tumor tissue available in the tumor bank
- Absence of Biological research center consent signed
Key Trial Info
Start Date :
April 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 23 2017
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT03367208
Start Date
April 12 2017
End Date
May 23 2017
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Antoine Lacassagne
Nice, Cedex 2, France, 06189